Cargando…
Targeting Nfix to fix muscular dystrophies
Muscular dystrophies (MDs) are still incurable heterogeneous diseases, characterized by muscle wasting, replacement by fibrotic tissue, and increasing weakness, which in severe cases, such as Duchenne MD, lead to premature death. MDs are due to mutations encompassing different dystrophin-glycoprotei...
Autores principales: | Rossi, Giuliana, Taglietti, Valentina, Messina, Graziella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shared Science Publishers OG
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551842/ https://www.ncbi.nlm.nih.gov/pubmed/31225448 http://dx.doi.org/10.15698/cst2018.01.121 |
Ejemplares similares
-
Silencing Nfix rescues muscular dystrophy by delaying muscle regeneration
por: Rossi, Giuliana, et al.
Publicado: (2017) -
Selective ablation of Nfix in macrophages attenuates muscular dystrophy by inhibiting fibro‐adipogenic progenitor‐dependent fibrosis
por: Saclier, Marielle, et al.
Publicado: (2022) -
Nfix Induces a Switch in Sox6 Transcriptional Activity to Regulate MyHC-I Expression in Fetal Muscle
por: Taglietti, Valentina, et al.
Publicado: (2016) -
Targeting of proteins to the twin‐arginine translocation pathway
por: Palmer, Tracy, et al.
Publicado: (2020) -
Mode of action of lipoprotein modification enzymes—Novel antibacterial targets
por: Legood, Simon, et al.
Publicado: (2020)